Comissões farmacoterapêuticas no Brasil: aquém das diretrizes internacionais

Abstract

The inadequate use of drugs leads to lack of therapeutic efficacy, adverse reactions, side effects, preventable drug interactions, increased bacterial resistance to antibiotics, and wasted resources. Changing this scenario is one of the most complex challenges facing health systems today. One approach used to rationalize the use of drugs lies in the creation of pharmacy and therapeutics committees, whose main role is to guide and assist health institutions at all levels in selecting drugs and monitoring their use, training professionals to use drugs rationally, and collecting systematized information to guide new strategies and actions. Brazil, unlike other parts of the world, does not make it compulsory to have pharmacy and therapeutics committees. Although committees for monitoring hospital infections are compulsory in that country, their action is restricted to hospitals and is not as broad as that proposed for pharmacy and therapeutics committees. Data from 2003 shows that among 250 public and private hospitals in Brazil, only 29 had pharmacy and therapeutics committees. It is essential that the need to make these committees compulsory at all levels of the Brazilian health system be discussed, and that the national Ministry of Health and other related agencies create the conditions necessary for the establishment of pharmacy and therapeutics committees, in accordance with other health policies currently in place.

Added therapeutic value of new drugs approved in Brazil from 2004 to 2016

“…Our study has shown that only 36 (14.2%) of the new medicines registered during these 13 years were listed for public coverage under the SUS, and that 21 out of the 36 medicines included in these listings were considered non-innovative by both CMED and Prescrire. Such a low number of therapeutic innovations stresses the importance of strengthening pharmacy and therapeutics committees 39,40,41 . While they have been established in many health facilities in Brazil, their roles are somewhat limited due to financial and human resources constraints 41 .…”

Atuação da comissão de farmácia e terapêutica em um hospital de ensino

“…Estas funções são de extrema importância para a melhoria da gestão, mas no caso do estudo ainda não ocorre de fato. 2,5 Visando buscar ferramentas que minimizem e eliminem as discrepâncias entre as indicações do protocolo e a dispensação do medicamento, as seguintes propostas foram elaboradas:…”

“…Estudos mostram que em países desenvolvidos como Canadá e Estados Unidos as CFTs possuem papel fundamental nas variáveis econômicas, sociais, sanitári-as para avaliar a incorporação de medicamentos a padronização das unidades hospitalares. 2,5 No Brasil, a atuação das CFTs é incipiente e existem poucos estudos sobre a sua existência e a metodologia de trabalho utilizada. 1,5 Portanto, o presente estudo pretende apresentar a CFT do HCFMRP-USP quanto a sua funcionalidade e desenvolver uma análise crítica do seu atual funcionamento.…”

“…2,5 No Brasil, a atuação das CFTs é incipiente e existem poucos estudos sobre a sua existência e a metodologia de trabalho utilizada. 1,5 Portanto, o presente estudo pretende apresentar a CFT do HCFMRP-USP quanto a sua funcionalidade e desenvolver uma análise crítica do seu atual funcionamento. Para conhecermos com detalhes o funcionamento da CFT no HCFMRP-USP, buscamos portarias e regulamentações internas, além de dados relativos à sua atuação.…”

The medicine selection process in four large university hospitals in Brazil: Does the DTC have a role?

“…DTC activities are well established in most European countries, the USA, Canada and Australia. In Brazil, these committees are non-mandatory, and their implementation has not been forthcoming (Marques, Zucchi, 2006;Veber et al, 2011). A 2003 national assessment showed that a mere 29 (11%) of 250 investigated hospitals presented nominal DTCs, but operational DTCs were seen in only 3.6% of hospitals (Osorio-de-Castro, Castilho, 2004).…”